Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Blood Tests Help Identify Children Who Need Appendectomy

By LabMedica International staff writers
Posted on 04 Mar 2015
Appendicitis is the most common abdominal surgical emergency in the pediatric population, yet the diagnosis remains challenging in many cases and the use of laboratory data as a diagnostic adjunct has similarly been associated with relatively low sensitivity, and children with pathology-proven appendicitis can often present with a normal leukocyte count.

Two standard diagnostic tests commonly obtained in children evaluated for abdominal pain—when combined can improve the ability of emergency department physicians and pediatric surgeons to identify those patients who should be sent to the operating room for prompt removal of an inflamed appendix and those who may be admitted for observation, and those who may safely be discharged home.

Medical staff at the Boston Children's Hospital (Boston, MA, USA) conducted a retrospective cohort study of 845 patients, three to 18 years of age, who were evaluated in an emergency department with a chief symptom of abdominal pain between January 1, 2010 and December 31, 2012. Negative (NPV) and positive predictive values (PPV) for appendicitis were calculated for common constellations of US findings and compared with and without the use of laboratory thresholds: white blood cell count (WBC) >9 × 103/mL and polymorphonuclear leukocyte differential (PMN%) >65% for PPV; WBC <9 × 103/mL and PMN% <65% for NPV. Ultrasound reports were reviewed using standardized definitions and case report forms.

Of the 845 children in the study, 393 (46.5%) had appendicitis. An elevated WBC count was found in 348 (62.1%) of these patients, and a PMN% shift was found in 340 (58.5%). In children who did not have appendicitis, the WBC was elevated in 212 (37.9%), and the PMN% shift occurred in 241 (41.5%). The ability to identify children with and without appendicitis was significantly improved when sonography and laboratory findings were paired. The risk of appendicitis rose from 79.1% to 91.3% when laboratory studies indicated a bacterial infection and sonography showed primary signs of appendicitis, such as increased blood flow or a thickening in the wall of the appendix. The risk of appendicitis rose from 89.1% to 96.8% when laboratory results were abnormal and the sonogram showed secondary signs of appendicitis, such as fat near the appendix.

Shawn J. Rangel, MD, MSCE, FACS, the lead study author and pediatric surgeon said, “Any institution can read our study and readily reproduce what we did. We are not advocating that other hospitals adopt our sonographic categories or laboratory value cut-offs for WBC and PMN values, but rather to work collaboratively with their radiologists and emergency room physicians to develop their own approach for categorizing sonographic findings in their patients with suspected appendicitis, and then develop risk profiles that are tailor-made for their patients after incorporation of their institution's laboratory data. Institutions can use the risk profiles as educational vehicles and clinical guidelines decision tools to help emergency department physicians and surgeons avoid unnecessary computed tomography (CT) scans and admissions for observation for very low-risk patients, and avoid treatment delays in very high-risk patients.” The study was published online on January 30, 2015, in the Journal of the American College of Surgeons.

Related Links:

Boston Children's Hospital



Gold Member
Veterinary Hematology Analyzer
Exigo H400
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Troponin I Test
Quidel Triage Troponin I Test
New
High Performance Centrifuge
CO336/336R
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.